GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
pharmaphorum1d
FDA set to decide on GSK's gepotidacin antibiotic in March
according to GSK. At the same time, antimicrobial resistance (AMR) to common drugs used to treat these infections is on the rise, leading to treatment failure, with a Singapore study published ...
pharmaphorum3d
Sanofi opens $595m manufacturing facility in Singapore
at the heart of Singapore's life sciences hub. Tuas is home to upwards of 14 companies employing around 7,000 employees, with Amgen, GSK, Pfizer, AbbVie, MSD, Novartis, and Roche among Sanofi's ...
American Association of Individual Investors1d
Why Wave Life Sciences Ltd.’s (WVE) Stock Is Down 10.08%
Wave Life Sciences Ltd.’s WVE share price has dipped by 10.08%, which has investors questioning if this is right time to buy.
The Motley Fool UK3d
Should I buy GSK shares at £15?
Learn More. Just over a year ago, I ran the rule over GSK (LSE: GSK) shares. They looked very cheap and were offering a growing dividend. However, I chose instead to invest in FTSE 100 ...
Stockhouse5d
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
New York, New York--(Newsfile Corp. - March 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) ...
The Business Times2d
AstraZeneca seeks to move past China probe with Beijing R&D hub
HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...